Home LiteratureArticle Details
PMID: 22044372 Published · ppublish English

Variation in the BRCA2 gene in a child with medulloblastoma and a family history of breast cancer.

Journal of neurosurgery. Pediatrics ·Vol. 8 ·No. 5 ·2011-12-22

Bayrakli Fatih, Akgun Bekir, Soylemez Burcak, Kaplan Metin, Gurelik Mustafa

Abstract

The fact that BRCA genes operate as tumor suppressors is evident from the genetics of the different human disorders caused by inherited mutations. Germline mutations affecting 1 allele of either BRCA1 or BRCA2 confer susceptibility to different types of cancers such as breast cancer and medulloblastoma. A family with a history of cancer was identified in Eastern Turkey in which one of the family members (a 13-year-old boy) had medulloblastoma. Venous blood was collected from available family members. The BRCA1 and BRCA2 genes were sequenced in the patient with medulloblastoma and the healthy father. An Asn372His homozygous variation was noted in the BRCA2 gene in the patient with medulloblastoma whereas the variation was heterozygous in the healthy father. A biallelic homozygous variation was demonstrated in the BRCA2 gene, which is important in medulloblastoma suppression, and may have caused medulloblastoma formation in the 13-year-old boy. Further investigations in large human populations with medulloblastoma are necessary for further delineation of BRCA gene malfunctions and their relationship to medulloblastoma formation, and to clarify the therapeutic implications of these malfunctions.

Article Info
Journal
Journal of neurosurgery. Pediatrics
Abbr.
J Neurosurg Pediatr
Published
2011-12-22
Indexed
2011-11-02
Updated
2011-11-02
Language
English
Country/Region
United States
NLM ID
101463759
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com